The novel coronavirus, COVID-19, caused by SARS-CoV-2, is a global health pandemic that started in December 2019. The effective drug target among coronaviruses is the main protease Mpro, because of its essential role in processing the polyproteins that are translated from the viral RNA. In this study, the bioactivity of some selected heterocyclic drugs named Favipiravir (1), Amodiaquine (2), 2′-Fluoro-2′-deoxycytidine (3), and Ribavirin (4) was evaluated as inhibitors and nucleotide analogues for COVID-19 using computational modeling strategies. The density functional theory (DFT) calculations were performed to estimate the thermal parameters, dipole moment, polarizability, and molecular electrostatic potential of the present drugs; additionally, Mulliken atomic charges of the drugs as well as the chemical reactivity descriptors were investigated. The nominated drugs were docked on SARS-CoV-2 main protease (PDB: 6LU7) to evaluate the binding affinity of these drugs. Besides, the computations data of DFT the docking simulation studies was predicted that the Amodiaquine (2) has the least binding energy (−7.77 Kcal/mol) and might serve as a good inhibitor to SARS-CoV-2 comparable with the approved medicines, hydroxychloroquine, and remdesivir which have binding affinity −6.06 and −4.96 Kcal/mol, respectively. The high binding affinity of 2 was attributed to the presence of three hydrogen bonds along with different hydrophobic interactions between the drug and the critical amino acids residues of the receptor. Finally, the estimated molecular electrostatic potential results by DFT were used to illustrate the molecular docking findings. The DFT calculations showed that drug 2 has the highest of lying HOMO, electrophilicity index, basicity, and dipole moment. All these parameters could share with different extent to significantly affect the binding affinity of these drugs with the active protein sites.

No abstract

No abstract

No abstract

New types of angular 1:1 hydrogen-bonded supramolecular complexes via hydrogen-bond formation between 4-alkoxyphenylazo benzoic acids (In) and 4-(3ʹ-pyridylazo)-4ʹʹ-alkoxybenzoates (IIm) with various alkoxy chains (from 6 to 16 carbons) were prepared and investigated for their mesophase behaviour by differential scanning calorimetry (DSC) and polarised-light microscopy (PLM). All prepared homologues were found to be dimorphic, possessing smectic C and nematic mesophases. The formation of 1:1 hydrogen-bonded supramolecular liquid crystals (LCs) complexes was confirmed by FTIR and UVʹvisible (UVʹvis) absorption spectroscopy. The study revealed that nematic transition enhancement (ΔT) decreases with the increase of the alkoxy chain length on the base complement, while it increases with the increase of the chain attached to the acid complement of the complex, that is the stability of the nematic phase is more dependent on the length of the acid component.

A new series of chair-shaped liquid crystalline complexes were formed through 1 : 1 intermolecular hydrogen bonding between 4-(4-(hexyloxyphenylimino)methyl)phenyl nicotinate and 4-alkoxybenzoic acids, with different alkoxy chains.

No abstract

No abstract